Commissioning AIM Company Research

AIM Research notes can play a key role in an investors decision whether to invest (or NOT) in your AIM quoted company.

AIM Research is commissioned to offer an independent view of your companies' performance over a long or short period. The research note will rarely offer a specific recommendation, rather spell out the facts and key drivers that would influence a potential investor to make the decision to invest in your AIM company. Analysts will often look back and inevitably forward, speculating as to how your company is expected to perform over the next financial period. AIM Research comprises of a variety of publications from single page 'bulletins' that respond to a significant company event or change, through to larger multi-page pieces that respond to the Reports & Accounts or Annual General Meeting (AGM).

This valuable AIM research is distributed to brokers and released on the investor relations part of your website for investors to access, it is a key part of your Investor Communications.

Key to a good research note, is a good analysts. You require analysts that understand your sector and the competition in your market territory to effectively write a piece that is informed, relevant and easy to digest.

Good research notes come from a research house that really 'knows' your company, and the old adage 'you get what you pay for' is generally true.

There are a large variety of Research Houses in the market place from small to large teams, both can offer very high quality research so don't always assume bigger is better, quite often the smaller teams will be closer to the market, be more dedicated and/or specialist.

As well as pooling the best of the best for distribution on aimlisting.co.uk. we can offer superb, well written research through our selected partners.

Our research notes are prepared for us using information that is generally freely available.  This can be from your company’s own website or other sources.  In terms of financial forecasts, we will use forecasts that are available in the market so that we are in line with other analysts. With this information at hand we can usually prepare a note within a few days, crucial if a client company needs a note publishing to coincide with its interim or annual results. If this is the case, then to speed up the process both ourselves and our partners are used to being made 'insiders', our partners are all authorised and regulated by the Financial Conduct Authority. Results can therefore be supplied in confidence before they are released to the market to enable notes to be prepared.

It is also important to point out that no notes are distributed without approval by the client company and embargoes are applied when required.

Our Research Notes start at £1950+VAT for individual notes of circ. 4-6 pages. We can also offer a range of  tailored 6 month or annual packages.

The impact of regulation

The introduction of MiFID II (Markets in Financial Instruments Directive II) on 3 January 2018 has changed the way in which stock market research is regulated.  Under the new Europe-wide regulations, the costs of research and trading need to be split out and clearly identified when charged to a client.  The effect of this has been a reduction in the amount of research produced in general, with smaller quoted companies particularly affected.  This makes it even harder than ever for small companies to attract the attention of investors or potential investors.

If you would like to know a little more, please drop us a note below. One of our team will come back to discuss your research note needs.

    Research Enquiry

    We have a selection of notes written about a variety of AIM companies available to view and download.

    When advanced search panel to find AIM companies, ensure you select 'Research Available' in the 'more filters' section to find companies on which we have research.

    VIEW RESEARCH